Seven-membered vibsane diterpenoid compound and its preparation and application

By isolating and preparing seven-membered vibsane diterpenes from coral leaves, the problem of poor efficacy of existing anti-cancer drugs on infinite replication cancer cells was solved, demonstrating significant cytotoxic activity on lung cancer cells and potential treatment of lung cancer. Drug value.

CN114195641BActive Publication Date: 2024-11-08SHENYANG PHARMA UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202010985719.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-09-18
Publication Date
2024-11-08
Estimated Expiration
2040-09-18

AI Technical Summary

Technical Problem

Existing anti-cancer drugs are difficult to effectively target cancer cells with infinite replication, resulting in limited therapeutic effects and the development of anti-cancer drugs in natural products has not yet been fully utilized.

Method used

Seven-membered vibsane diterpenoid compounds were isolated from the coral leaves of Viburnum, and optically pure compounds were obtained through multi-step extraction and purification techniques. Specific steps include industrial ethanol extraction, ethyl acetate extraction, and silica gel column chromatography gradient washing. De-HPLC was prepared, the structure of the compound was determined and named vibsanolide A-G.

Benefits of technology

The compound has significant cytotoxic activity on lung cancer cell A549, especially vibsanolide B has significant cytotoxic activity on A549 cells, with an IC50 value of 1.11 μM, and it reduces mitochondrial membrane potential by inducing apoptosis and promoting reactive oxygen production, showing the potential prospects for anti-lung cancer drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114195641B_ABST
    Figure CN114195641B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of medical technology, and relates to a seven-membered vibsane diterpenoid compound, a preparation thereof, and an application thereof, and specifically relates to a seven-membered vibsane diterpenoid compound, a preparation thereof, and an application thereof in the preparation of a drug for treating tumors. The compound is isolated from the leaves of Viburnum odoratissimum Ker-Gawl.var.odoratissimum, a plant of the genus Viburnum of the family Caprifoliaceae. The present invention utilizes the leaves of Viburnum odoratissimum to extract, extract, and pass through silica gel column chromatography, HP-20 column chromatography, and ODS column chromatography, and then pass through silica gel column chromatography and preparative HPLC to obtain compound 1-7. The compound has significant anti-tumor activity, and in particular has significant anti-lung cancer effect. #imgabs0#
Need to check novelty before this filing date? Find Prior Art

Description

Technical field:

[0001] The invention belongs to the field of medical technology, and relates to a seven-membered vibsane diterpenoid compound and a preparation and application thereof, and specifically relates to a seven-membered vibsane diterpenoid compound and a preparation and application thereof in preparing a drug for treating tumors. Background technology:

[0002] Viburnum odoratissimum Ker-Gawl.var.odoratissimum: It belongs to the Caprifoliaceae family and the genus Viburnum. It is mainly produced in my country and distributed in southeastern Fujian, southern Hunan, Guangdong, Hainan, Guangxi and other places. Its roots and leaves can be used as medicine, which has the effects of clearing away heat and dampness, promoting blood circulation, removing toxins and promoting tissue regeneration. It is mainly used to treat rheumatism, swelling and pain caused by falls, and fractures.

[0003] Cancer: also known as malignant tumor. The human body needs to continuously produce new cells to replace aging and dead cells in order to maintain the normal function of the body. Therefore, most cells can replicate themselves. However, this replication is limited by the length of telomeres and can usually only divide 50 to 60 times. Cancer cells are the basic units that cause cancer lesions. Because they have telomerase, they can repair telomeres lost during the replication process and can replicate indefinitely. This will consume a large amount of nutrients in the body and release a variety of toxins, causing weight loss, weakness, anemia, loss of appetite, fever, and organ damage. Therefore, it is of great significance to find drugs with anti-cancer potential in natural products. Summary of the invention:

[0004] The present invention provides 7 seven-membered vibsane diterpenoid compounds or their salts:

[0005]

[0006] The compound is isolated from the leaves of Viburnum odoratissimum Ker-Gawl.var. odoratissimum, a plant of the genus Viburnum of the family Caprifoliaceae.

[0007] The preparation technology scheme of the present invention comprises the following steps:

[0008] A method for preparing a seven-membered vibsane diterpenoid compound using coral leaves, characterized in that:

[0009] (1) extracting dried coral leaves with 70-80% industrial ethanol, concentrating the extract to obtain an extract, and extracting the extract with ethyl acetate;

[0010] (2) the ethyl acetate extract was concentrated and the resulting extract was subjected to silica gel column chromatography using a gradient elution of 100:1-1:1 dichloromethane / chloroform-methanol to collect 9 fractions AI in total;

[0011] (3) Fraction B was further subjected to silica gel column chromatography with a gradient elution of petroleum ether-ethyl acetate system 30:1-20:1 to obtain three components B1, B2, and B3;

[0012] (4) Component B2 was subjected to HP-20 column chromatography with a gradient elution of ethanol-water system from 20% to 80% (20%, 40%, 60%, 80%) to obtain three components B 2.1 , B 2.2 , B 2.3 ;

[0013] (5) B2.3 was further subjected to ODS column chromatography with an ethanol-water system 20:80-90:10 gradient elution to obtain 10 components B 2.3.1 -B 2.3.10 ;

[0014] (6) Component B obtained 2.3.9 The mixture was purified by silica gel column chromatography with a petroleum ether-ethyl acetate system of 50:1-1:1 for gradient elution, and the obtained fractions were purified by preparative and semi-preparative HPLC with acetonitrile-water (45:55-50:50) to give compound 1-5.

[0015] (7) The obtained component B2.3.10 was subjected to silica gel column chromatography with a petroleum ether-ethyl acetate system of 50:1-1:1 for gradient elution, and the obtained component was subjected to preparative and semi-preparative HPLC with acetonitrile-water (65:35-70:30) to obtain compounds 6 and 7. The extraction in step (1) is reflux extraction, and the extraction is performed 3 to 5 times, each time for 2 to 3 hours.

[0016] In step (1), the coral leaves refer to the dried leaves of Viburnum odoratissimum Ker-Gawl. var. odoratissimum of the Caprifoliaceae family.

[0017] The obtained compounds were systematically identified and the results are as follows:

[0018] The structures of compounds 1-7 were identified by high-resolution mass spectrometry, one-dimensional NMR, two-dimensional NMR and calculated ECD. vibsanolide A (1): colorless oil (methanol), (c 0.20,MeOH); UV(MeOH)λ max (logε): 230 nm (0.49); HRESIMS gives a quasi-molecular ion peak m / z 439.2097 [M+Na]+ (calcd for C 24 H 32 NaO6,439.2097), combined 1 H, 13 C-NMR data confirmed that its molecular formula is C 24 H 32 O6, calculated unsaturation is 9, 1 In the H-NMR (600MHz, CD3OD) spectrum, δ H 6.98 (1H, d, J = 12.3 Hz), 5.31 (1H, dd, J = 12.3, 11.4 Hz); 6.92 (1H, dt, J = 15.6, 7.8 Hz), 6.11 (1H, dt, J = 15.6, 1.3 Hz) are hydrogen signals on two groups of trans double bonds, δ H 6.61 (1H, ddt, J = 8.9, 5.5, 1.6 Hz), 5.74 (1H, d, J = 1.3 Hz) are the proton signals on two different double bonds, δ H 4.27 (1H, dd, J = 14.0, 1.6 Hz), 4.19 (1H, dd, J = 14.0, 1.6 Hz) are two oxymethylene protons, δ H 2.28 (3H, s), 2.20 (3H, d, J = 1.3 Hz), 2.13 (3H, s), 1.97 (3H, d, J = 1.3 Hz), 1.00 (3H, s) indicate five methyl proton signals. 13 The C-NMR (150 MHz, CD3OD) spectrum shows a total of 24 carbon atoms, of which δ C 205.9 (C-4), 210.2 (C-7), 201.2 (C-15) indicate ketone carbonyl carbon signals, δ C 164.6 (C-1'), 115.3 (C-2'), 162.1 (C-3') suggest the presence of an α, β unsaturated ester structure fragment, δ C 139.2(C-8),113.5(C-9);δ C 143.8 (C-3), 137.1 (C-2); 134.8 (C-14), 147.3 (C-13) are three groups of double bond carbon signals, δ C 62.2 (C-18) is the oxygen-linked carbon signal, δ C26.9 (C-16), 30.0 (C-19), 20.5 (C-4'), 27.6 (C-5'), 23.8 (C-20) are five methyl carbon signals. The above hydrocarbon data show that the compound is a seven-membered ring vibsane-type diterpene compound. All signals are assigned by HSQC, and the compound is further analyzed by combining with other two-dimensional spectra.

[0019] 1 H- 1 In H COSY, three coupling fragments H2-12 / H-13 / H-14, H-6 / H-5 / H-10 / H-9 / H-8, and H2-1 / H-2 can be observed. In the HMBC spectrum, H2-18 (δ H 4.27,4.19) and C-2(δ C 137.1),C-3(δ C 143.8),C-4(δ C 205.9), indicating that the hydroxymethyl group is connected to C-3 and C-2-C-3-C-4. H 2.13) and C-7(δ C 210.2), C-6(δ C 44.7), indicating that H3-19 is attached to C-7. H 3.06) and C-4 (δ C 205.9), indicating the presence of C-4-C-5 fragment. H 1.00) and C-10(δ C 45.6),C-11(δ C 42.4),C-12(δ C 44.2),C-1(δ C 37.3) is related, indicating the connection of C-10-C-11-C-1 fragments. H 6.98) and C-1'(δ C 164.6), indicating that the α,β unsaturated ester structure is attached to C-8. H 6.11) and C-12(δ C 44.2) is related, H-13(δ H 6.92) and C-15 (δ C 201.2) is related, indicating that the carbonyl group is connected to the double bond; H3-16 (δ H 2.28) and C-15(δ C201.2), indicating that the methyl group is connected to the carbonyl group, thus determining the structure of the side chain. H 2.23) and C-11(δ C 42.4), indicating that the side chain is attached to C-11. Therefore, the planar structure of compound 1 was determined and named vibsanolide A.

[0020] The relative configuration of the compound was determined by NOESY spectrum. In NOESY, the correlation between H-8 and H-10 can be observed, indicating that these two hydrogens are α-oriented; H-9 is correlated with H3-20 and H-5, indicating that these hydrogens are β-oriented, thus determining the relative configuration of the compound to be 5S*, 10S*, 11S*.

[0021] The absolute configuration of the compound was determined by comparing the calculated and measured ECD curves. The measured ECD curve of the compound is in good agreement with the calculated 5S, 10S, 11S ECD curves, so the absolute configuration of the compound was determined to be 5S, 10S, 11S.

[0022] vibsanolide B(2): colorless oil (methanol), (c 0.30, MeOH); UV(MeOH)λ max (logε): 224nm (0.55); HRESIMS gives a quasi-molecular ion peak m / z 421.2225 [M+H] + (calcd for C 23 H 33 O7, 421.2226), combined 1 H, 13 C-NMR data confirmed that its molecular formula is C 23 H 32 O7, calculated unsaturation is 8. 1 The HNMR (600 MHz, CD3OD) spectrum showed isopentenyl proton signals [δ H 2.21 (3H, d, J = 1.3 Hz), 1.97 (3H, d, J = 1.3 Hz), 5.74 (1H, d, J = 1.3 Hz)], two methyl proton signals [2.14 (3H, s), 0.93 (3H, s)], one methoxy signal [δ H 3.66 (3H, s)], three olefin proton signals [δ H 6.99(1H,d,J=12.3Hz), 5.29(1H,dd,J=12.3,11.4Hz), 6.62(1H,ddt,J=8.8,5.5,1.6Hz)]. 13C NMR showed a total of 23 carbon signals, including two ketone carbonyl signals, two ester carbonyl signals, six olefin carbon signals and five methyl signals. By comparing the NMR spectrum with compound 2, it was found that the two were analogs, the difference being that the C-11 side chain of compound 2 lost a carbon signal and was replaced by a side chain with an ester carbonyl. C 35.6), H2-12 / H2-13 / OCH3-14 and C-14 (δ C 176.0) confirmed the connection mode of C-11 side chain. The relative configuration of compound 2 was determined by NOESY. The correlation of H-8 / H-10 in the NOESY spectrum showed that H-8 and H-10 were located on the same side of the plane in the α direction, and the correlation of H3-20 / H-9, H-5 / H3-20, H-5 / H-1β and H2-12 / H-1α showed that H3-20 and H-5 were in the β direction. By comparing the measured and calculated ECD spectra, the absolute configuration of the compound was determined to be 5S, 10S, and 11S.

[0023] vibsanolide C(3): colorless oil (methanol), (c 0.20,MeOH); UV(MeOH)λ max (logε): 225nm (0.31); HRESIMS gives the quasi-molecular ion peak m / z 453.2251 [M+Na] + (calcd for C 25 H 34 NaO6,453.2248), combined 1 H, 13 C-NMR data confirmed that its molecular formula is C 25 H 34 O6, calculated unsaturation is 9.

[0024] 1 H / 13The C NMR spectrum showed 25 carbon signals including 5 methyl signals, 6 methylene signals, 6 methine signals, and 8 quaternary carbon signals. The above data also indicate the presence of four groups of double bond signals, two groups of carbonyl signals and one group of ester carbonyl signals. Considering that the degree of unsaturation of the compound is 9, it is suggested that compound 3 is a compound with a single ring system skeleton. By comparing with the known compound 5-epi-vibsanin H, it is shown that compound 3 is highly similar to the known compound. The only difference is that there is a significant difference in chemical shift at C-14. Further two-dimensional spectrum analysis showed that compound 3 is a C-14 oxide with a classic seven-membered ring vibsane-type diterpene carbon skeleton similar to the 5-epi-vibsanin H plane. Among them, the HMBC spectrum shows that H3-20 is correlated with C-11, C-1, and C-10; H2-6 is correlated with C-4, C-5, and C-10; H2-18 is correlated with C-2, C-3, and C-4, and H-2 is correlated with C-1, C-11, and C-4, indicating that the planar structure of compound 5 is a seven-membered ring vibsane-type diterpene carbon skeleton with an α,β-unsaturated ketone. In the HMBC spectrum, the correlation of H3-19 with C-7, C-6, and the correlation of H2-6 with C-4, C-5, and C-10 indicate that the subunit acetyl group is connected to the C-5 position. In addition, the HMBC correlation of H-8 with C-9 and C-10 indicates that the side chain double bond is connected to C-10, and at the same time, H-8 is correlated with C-1'(δ C 163.1) shows that the correlation between C-8 and C-1' (δ C 163.1) connected via oxygen atoms. Finally, the side chain at C-11 is connected by observing that H3-20 is connected to C-12 and H2-13 is connected to C-12, C-14 (δ C 202.7) and H2-16 / H3-17 and C-15 (δ C 144.2), HMBC correlation of C-14, thus confirming that the connection is at C-11. Therefore, the planar structure of compound 3 was determined and named vibsanolide C.

[0025] The relative configuration of compound 3 was determined by NOESY spectrum. H-5 was correlated with H-1 and H-12 NOESY, and H-5 lacked NOESY correlation with H-9 and H3-20, indicating that H-10 was in the same direction as H-5 and H2-12. Therefore, the relative configuration of these positions was determined to be 5R*, 10S*, 11S*. The absolute configuration of the compound was determined by comparing the calculated and measured ECD. The measured ECD curve of the compound was well matched with the calculated 5R, 10S, 11S configuration ECD curve, so the absolute configuration of the compound was determined to be 5R, 10S, 11S.

[0026] vibsanolide D(4): colorless oil (methanol), (c 0.20,MeOH); UV(MeOH)λ max (logε): 230nm (0.55); HRESIMS gives a quasi-molecular ion peak m / z 469.2594 [M+Na] + (calcd for C 26 H 38 NaO6, 469.2561), combined 1 H, 13 C-NMR data confirmed that its molecular formula is C 26 H 38 O6, calculated unsaturation is 8.

[0027] 1 The H NMR (600 MHz, CD3OD) spectrum showed isopentenyl proton signals [δ H 2.21 (3H, d, J = 1.4 Hz), 1.96 (3H, d, J = 1.4 Hz), 5.72 (1H, d, J = 1.4 Hz)], 4 methyl signals [2.17 (3H, s), 0.87 (3H, s), 1.76 (3H, d, J = 1.4 Hz), 1.78 (3H, d, J = 1.4 Hz)], 4 olefin proton signals [δ H 7.07 (1H, d, J = 12.3Hz), 5.02 (1H, overlapped), 5.06 (1H, overlapped), 6.67 (1H, ddt, J = 7.7, 5.5, 1.5Hz)]. 13 C NMR and HSQC spectra showed that compound 4 had the same seven-membered ring vibsane diterpenoid skeleton as compound 3, indicating that the two compounds were analogs. The difference was that compound 4 had a methoxy group at C-13 and the double bond position of the side chain at C-11. C 127.8),C-15(δ C 136.5), H3-20 and C-12 (δ C 49.9), C-13(δ C 75.8) are related, OCH3-13 and C-13 (δ C 75.8), confirming the connection mode of the C-11 side chain. Therefore, the planar structure of compound 4 was determined.

[0028] The relative configuration of the compound was determined by NOESY spectrum. The correlation of H-10 / H-8, H3-20 / H-9, H-5 / H-12 and H-5 / H-1a was observed in the NOESY spectrum, indicating that H-10 and H-5 were in the α direction and H3-20 was in the β direction. Since OCH3-13 is on a flexible chain, its relative configuration cannot be determined. Therefore, the ECD of the two absolute configurations (5R,10S,11R,13S)-4a and (5R,10S,11R,13R)-4b was calculated to try to determine the relative configuration of C-13. By comparison, it was found that the two calculated ECD spectra were almost the same, so the configuration of C-13 could not be determined by calculating ECD. It also shows that the configuration of C-13 has almost no effect on the determination of the configuration of other chiral centers, so the absolute configurations of the other three chiral centers were determined to be 5R,10S,11R.

[0029] The NMR data of compounds 1-4 are shown in Table 1

[0030] Table 1 Compound 1-4 (a: CD3OD and b: CDCl3) 1 H(600MHz) and 13 C (150 MHz) NMR data

[0031]

[0032]

[0033] vibsanolide E(5): colorless oil (methanol), (c 0.20,MeOH); UV(MeOH)λ max (logε): 232nm (0.94); HRESIMS gives a quasi-molecular ion peak m / z 469.2559 [M+Na] + (calcd for C 26 H 38 NaO6, 469.2561), combined 1 H, 13 C-NMR data confirmed that its molecular formula is C 26 H 38O6, and its unsaturation degree is calculated to be 8. Comparison of its NMR spectrum with that of compound 4 revealed that the two compounds have the same planar structure, except that the configuration of H-5 is different. The correlation of H-8 / H-10, H-5 / H3-20, and H3-20 / H-9 in the NOESY spectrum determined that the relative configuration of the compound is (5S*, 10S*, 11R*). Similar to the case of compound 4, the relative configuration of OCH3-13 cannot be determined because it is on a flexible chain. Therefore, the ECDs of the absolute configurations of (5S, 10S, 11R, 13S)-5a and (5S, 10S, 11R, 13R)-5b were calculated to determine the configuration of C-13. The two similar calculated ECD spectra indicate that the configuration of C-13 cannot be determined by calculating the ECD. At the same time, it indicates that the configuration of C-13 has almost no effect on the determination of the configurations of other chiral centers. Therefore, the absolute configurations of the other three chiral centers were determined to be 5S, 10S, and 11R.

[0034] vibsanolide F(6): colorless oil (methanol), (c 0.10,MeOH); UV(MeOH)λ max (logε): 229nm (0.59); HRESIMS gives a quasi-molecular ion peak m / z 385.1992 [M+Na] + (calcd for C 21 H 30 NaO5,385. 1985), combined 1 H, 13 C-NMR data confirmed that its molecular formula is C 21 H 30 O5, calculated unsaturation is 7.

[0035] exist 1 In the H-NMR (600MHz, CDCl3) spectrum, δ H 7.12 (1H, d, J = 12.4 Hz), 5.14 (1H, dd, J = 12.4, 10.9 Hz) are hydrogen signals on a group of trans double bonds, δ H 3.67 (1H, dd, J = 12.1, 4.7 Hz), 4.21 (1H, dd, J = 12.1, 10.8 Hz) are two oxymethylene protons, δ H 2.21 (3H, d, J = 1.3 Hz), 2.13 (3H, s), 1.94 (3H, d, J = 1.3 Hz), 0.96 (3H, s) indicated four methyl proton signals. 13 The C-NMR (150 MHz, CDCl3) spectrum showed 21 carbon signals, of which δ C214.6 (C-4), 211.0 (C-7) indicate keto carbonyl carbon signals, δ C 163.4 (C-1'), 114.7 (C-2'), 160.6 (C-3') suggest the presence of an α, β unsaturated ester structure fragment, δ C 136.9 (C-8), 115.9 (C-9) are a group of double bond carbon signals, δ C 65.6 (C-18) is the oxygen-linked carbon signal, δ C 30.1 (C-19), 31.8 (C-20), 20.7 (C-4'), and 27.8 (C-5') are four methyl carbon signals. All signals were assigned by HSQC, and the compounds were further analyzed by combining the other two-dimensional spectra.

[0036] 1 H- 1 In H COSY, three spin coupling systems, H2-6 / H-5 / H-10 / H-9 / H-8, H2-1 / H-2 / H2-13 / H2-12 and H2-18 / H-3, can be observed. In HMBC, H2-18 (δ H 3.67,4.21) and C-2(δ C 40.4),C-3(δ C 63.4),C-4 (δ C 214.6), indicating that C-3 is connected to C-2, C-4, and C-18; H3-19 (δ H 2.13) and C-6(δ C 45.5),C-7(δ C 211.0), indicating the presence of the C-6-C-7-C-19 fragment; H3-20 (δ H 0.96) and C-11(δ C 43.6),C-10(δ C 51.9),C-1 (δ C 37.1),C-12(δ C 40.3), indicating that H3-20 is attached to C-11. Therefore, the planar structure of compound 6 was determined and named vibsanolide F.

[0037] The relative configuration of the compound was determined by NOESY. In the NOESY spectrum, it can be observed that H-8 and H-10 are correlated, indicating that H-8 and H-10 are in the α direction; the correlations of H-9 / H-5, H-9 / H3-20, H-5 / H-18 and H-5 / H-1b indicate that H-5 and H3-20 are in the β direction, and H-3 is in the α direction. Therefore, the relative configuration of the compound is determined to be 2R*, 3R*, 5S*, 10S*, 11S*.

[0038] The absolute configuration of the compound was determined by comparing the calculated and measured ECD curves. The measured ECD curve of the compound is well matched with the calculated 2R, 3R, 5S, 10S, 11S ECD curves, so the absolute configuration of the compound was determined to be 2R, 3R, 5S, 10S, 11S.

[0039] vibsanolide G(7): colorless oil (methanol), (c 0.20,MeOH); UV(MeOH)λ max (logε): 228nm (0.98); HRESIMS gives a quasi-molecular ion peak m / z 385.1975 [M+Na] + (calcd for C 21 H 30 NaO5,385. 1985), combined 1 H, 13 C-NMR data confirmed that its molecular formula is C 21 H 30 O5, calculated unsaturation is 7.

[0040] exist 1 In the H-NMR (600MHz, CDCl3) spectrum, δ H 7.08 (1H, d, J = 12.3 Hz), 5.05 (1H, dd, J = 12.3, 11.4 Hz) are hydrogen signals on a group of trans double bonds, δ H 3.59 (1H, dd, J = 11.5, 4.3 Hz), 3.79 (1H, dd, J = 11.5, 7.7 Hz) are two oxymethylene protons, δ H 2.21 (3H, d, J = 1.4 Hz), 2.10 (3H, s), 1.95 (3H, d, J = 1.4 Hz), 0.98 (3H, s) indicate four methyl proton signals. 13 The C-NMR (150 MHz, CDCl3) spectrum showed a total of 21 carbon signals, of which δ C 215.1 (C-4), 207.4 (C-7) indicate keto carbonyl carbon signals, δ C163.5 (C-1'), 114.9 (C-2'), 160.3 (C-3') suggest the presence of an α, β unsaturated ester structure fragment, δ C 137.0 (C-8), 111.1 (C-9) are a group of double bond carbon signals, δ C 64.4 (C-18) is the oxygen-linked carbon signal, δ C 29.9 (C-19), 29.6 (C-20), 20.7 (C-4'), 27.8 (C-5') are four methyl carbon signals. This compound has the same mass spectrum data as compound 6, and the carbon and hydrogen data of the two are very similar. The difference is that the chemical shift value of H-5 is quite different, so the two may be C-5 diastereomers. All signals are assigned in combination with the HSQC spectrum, and the compound is further analyzed in combination with the other two-dimensional spectra.

[0041] 1 H- 1 In H COSY, four spin coupling systems, H2-6 / H-5, H-10 / H-9 / H-8, H2-1 / H-2 / H2-13 / H2-12 and H2-18 / H-3, can be observed. In HMBC, H2-18 (δ H 3.59,3.79) and C-2(δ C 37.6),C-3(δ C 61.5),C-4(δ C 215.1), indicating that C-3 is connected to C-2, C-4, and C-18. H 2.10) and C-6(δ C 46.4),C-7(δ C 207.4) related, H2-6(δ H 2.33,3.13) and C-4(δ C 215.1), indicating the presence of the C-19-C-7-C-6-C-5-C-4 fragment. H 0.98) and C-11(δ C 46.6),C-10(δ C 50.9),C-12(δ C 39.7),C-1(δ C 39.1), indicating that H3-20 is attached to C-11. Therefore, the planar structure of compound 7 was determined and named vibsanolide G.

[0042] The relative configuration of the compound was determined by NOESY. In the NOESY spectrum, it can be observed that H-8 and H-10 are correlated, indicating that H-8 and H-10 are in the α direction; H-5 and H-3 are correlated, and the lack of correlation signals of H-9 / H-5, H-5 / H-1b indicates that H3-20 is in the β direction, and H-5 and H-3 are in the α direction. Therefore, the relative configuration of the compound is determined to be 2R*, 3R*, 5R*, 10S*, 11S*.

[0043] The NMR data of compounds 5-7 are shown in Table 2:

[0044] The absolute configuration of the compound was determined by comparing the calculated and measured ECD curves. The measured ECD curve of the compound is in good agreement with the calculated 2R, 3R, 5R, 10S, 11S ECD curves, so the absolute configuration of the compound was determined to be 2R, 3R, 5R, 10S, 11S.

[0045] Table 2 Compound 5-7 (a: CD3OD and b: CDCl3) 1 H(600MHz) and 13 C (150 MHz) NMR data

[0046]

[0047]

[0048] The cytotoxic activity and mechanism of the seven vibsane-type diterpenoid compounds described in the invention on tumor cells A549 and HepG2 were investigated. The results of in vitro cell experiments showed that the compounds of the present invention all had cytotoxic activity on A549 cells, especially compound 2 had significant cytotoxic activity on A549 cells, IC 50 The value is 1.11 μM. The mechanism results show that compound 2 can induce apoptosis of A549 cells, promote the production of cellular reactive oxygen species, and reduce mitochondrial membrane potential. Therefore, the vibsane-type diterpenes described in the present invention have the prospect of further development of drugs for the treatment of lung cancer.

[0049] The advantages of the present invention are that the compounds are all optically pure compounds with a definite stereoconfiguration and have strong anti-lung cancer activity, thus being worthy of further development. Description of the drawings:

[0050] Figure 1 UV spectrum of compound 1;

[0051] Figure 2 HRESIMS spectrum of compound 1;

[0052] Figure 3 UV spectrum of compound 2;

[0053] Figure 4 HRESIMS spectrum of compound 2;

[0054] Figure 5 UV spectrum of compound 3;

[0055] Figure 6 HRESIMS spectrum of compound 3;

[0056] Figure 7 UV spectrum of compound 4;

[0057] Figure 8 HRESIMS spectrum of compound 4;

[0058] Fig. 9 UV spectrum of compound 5;

[0059] Fig.10 HRESIMS spectrum of compound 5;

[0060] Fig.11 UV spectrum of compound 6;

[0061] Fig.12 HRESIMS spectrum of compound 6;

[0062] Fig.13 UV spectrum of compound 7;

[0063] Fig.14 HRESIMS spectrum of compound 7;

[0064] Fig.15 Key HMBC correlation and COSY correlation of compounds 1-7;

[0065] Fig.16 Key NOESY correlations of compounds 1-7;

[0066] Fig.17 Comparison of measured and calculated ECDs of compounds 1-7;

[0067] Fig.18 Compound 2 induces apoptosis of A549 cells.

[0068] (A) Cell morphology changes under phase contrast microscopy. (B) Hoechst 33324 staining to observe nuclear morphology changes. (C) AO / EB staining to observe apoptotic cells.

[0069] Fig.19 AV / PI double staining of compound 2-induced apoptosis in A549 cells.

[0070] Fig. 20 Compound 2 promotes ROS production and mitochondrial dysfunction.

[0071] (A) H2DCF-DA staining was used to examine the level of intracellular ROS. (B) MitoSOX staining was used to examine the level of ROS in mitochondria. (C) JC-1 staining was used to examine the changes in mitochondrial membrane potential. Specific implementation method:

[0072] The following examples are intended to help those skilled in the art to better understand the present invention, but are not intended to limit the present invention in any way.

[0073] Example 1: Preparation of Compound 1-7.

[0074] Take 40kg of dried coral tree (V.odoratissimum) leaves and extract them with 70% ethanol by reflux for 3 times, each time for 3 hours. Obtain 3000g of crude ethanol extract, extract with ethyl acetate and n-butanol, and concentrate the component (1000g) extracted with ethyl acetate. The extract is chromatographed on a silica gel column with a gradient elution of 100:1-1:1 dichloromethane / chloroform-methanol, and a total of 9 fractions AI are collected. Fraction B (500g) is further chromatographed on a silica gel column with a gradient elution of 30:1-20:1 of petroleum ether-ethyl acetate system to obtain three components B1, B2, and B3. Component B2 (150g) is chromatographed on a HP-20 column with a gradient elution of 20%, 40%, 60%, 80% of ethanol-water system to obtain 3 components B 2.1 , B 2.2 , B 2.3 . 2.3 Further ODS column chromatography with ethanol-water system 20:80-90:10 gradient elution gave 10 components B. 2.3.1 -B 2.3.10 ; Component B obtained 2.3.9 (6g) was subjected to silica gel column chromatography with a petroleum ether-ethyl acetate system of 50:1-1:1 for gradient elution, and the resulting fractions were subjected to preparative and semi-preparative HPLC with acetonitrile-water (50:50, v / v, 2.5 mL / min) to obtain compound 1 (6 mg), compound 4 (2.1 mg), and compound 5 (49 mg). Compound 2 (5 mg) and compound 3 (7.2 mg) were obtained with acetonitrile-water (43:57, v / v, 2.5 mL / min). 2.3.10 The product (13 g) was purified by silica gel column chromatography with a petroleum ether-ethyl acetate system of 50:1-1:1 for gradient elution, and the resulting fractions were purified by preparative and semi-preparative HPLC with acetonitrile-water (70:30, v / v, 2.5 mL / min) to give compound 6 (1 mg) and compound 7 (3 mg).

[0075] Example 2: Investigation of the antitumor activity of compounds 1-7 against lung cancer cells A549 and liver cancer cells HepG2 in vitro.

[0076] The MTT method was used to investigate the cytotoxic activity of compounds 1-7 against tumor cells A549 and HepG2. The cells were placed in a 96-well plate and cultured with culture medium for 12 hours. A549 and HepG2 cells were treated with compounds at different concentrations, and paclitaxel and sorafenib were used as positive control groups, respectively. After 48 hours of action, 20 μL of MTT reagent was added and placed at 37°C for 4 hours. The cells treated with different concentrations were detected using an enzyme reader at a wavelength of 490 nm. The results showed (Table 3) that compound 2 had significant cytotoxic activity against A549 cells, IC 50 The value was 1.11 μM, and compound 3 showed good cytotoxic activity against A549 and HepG2 cells. 50 The values ​​were 19.75 μM and 12.61 μM, respectively.

[0077] To investigate whether compound 2 can induce apoptosis in A549 cells, we used Hoechst staining and AO / EB staining to test compound 2. A549 cells were placed in a 24-well plate and treated with compound 2 for 48 hours. Cell morphology was observed using a phase contrast microscope. After washing the cells three times with PBS, they were stained with Hoechst 33324 or AO / EB. After 15 minutes in the dark, the morphological changes of the cells were observed using a fluorescence microscope. The results showed that after the cells were treated with compound 2, characteristic morphological changes of apoptosis, such as shrinkage and cell membrane blebbing, occurred (see Figure 2). Fig.18 A). After staining with Hoechst, nuclear fragments and chromatin condensation appeared (see Appendix Fig.18 B). AO / EB staining experiments revealed the presence of apoptotic cells stained yellow-green. The above experimental data indicate that compound 2 can induce apoptosis of A549 cells (see Appendix Fig.18 C). Then, the effect of compound 2 on the apoptosis rate of A549 cells was examined by AV / PI double staining experiment. A549 cells were placed in a 6-well plate and treated with compound 2 for 48 hours, then stained with Annexin V-FITC / PI in the dark for 15 minutes and tested by flow cytometry. The results showed that the apoptosis rate increased with the increase of compound concentration, and when the compound concentration was 2μM, the apoptosis rate reached 49.02% (Appendix Fig.19 ). The above results show that compound 2 can significantly induce apoptosis of A549 cells.

[0078] The effect of compound 2 on the production of reactive oxygen species (ROS) in cells was then investigated. A549 cells were placed in a 24-well plate and treated with compounds at concentrations of 0.5, 1, and 2 μM, respectively. After washing the cells three times with PBS, the cells were stained with H2DCF-DA or MitoSOX and observed under a fluorescence microscope. The results of H2DCF-DA staining showed that the DCF fluorescence intensity gradually increased with the increase in compound concentration, indicating that compound 2 can enhance the production of intracellular ROS (see Appendix). Fig. 20 A). MitoSOX staining results showed that the fluorescence intensity gradually increased with the increase of compound concentration, indicating that compound 2 can enhance the production of ROS in mitochondria (Appendix Fig. 20 B). At the same time, JC-1 staining experiments were performed to examine whether the cell apoptosis induced by compound 2 was related to mitochondrial dysfunction. The results showed that after A549 cells were stained with JC-1 reagent, the red fluorescence decreased and the green fluorescence increased, indicating a decrease in mitochondrial membrane potential, which further indicated that the cell apoptosis induced by compound 2 was related to mitochondrial dysfunction (Appendix Fig. 20 C).

[0079] Table 3 Cytotoxic activity

[0080]

[0081]

Claims

1. A vibsane-type diterpene compound or a salt thereof as shown in the following structure: .

2. A method for preparing the compound according to claim 1, characterized in that: (1) Extract the dried coral leaves with ethanol, concentrate the extract to obtain an extract, and extract the extract with ethyl acetate; (2) The ethyl acetate extract was concentrated and the resulting extract was subjected to silica gel column chromatography using a gradient elution of 100:1-1:1 dichloromethane / chloroform-methanol to collect 9 fractions AI in total; (3) Fraction B was further subjected to silica gel column chromatography with a gradient elution of petroleum ether-ethyl acetate system 30:1-20:1 to obtain three components B1, B2, and B3; (4) Component B2 was subjected to HP-20 column chromatography with a gradient elution of ethanol-water system from 20% to 80% to obtain three components B 2.1 , B 2.2 , B 2.3 ; (5) B 2.3 Further ODS column chromatography with ethanol-water system 20:80-90:10 gradient elution gave 10 components B. 2.3.1 -B 2.3.10 ; (6) Component B obtained 2.3.9 The product was subjected to silica gel column chromatography with a petroleum ether-ethyl acetate system of 50:1-1:1 for gradient elution, and the obtained fractions were subjected to preparative and semi-preparative HPLC to obtain compounds 2 and 3; The mobile phase of semi-preparative HPLC in step (6) was acetonitrile-water 43:

57.

3. The preparation method according to claim 2, characterized in that: The ethanol in step (1) is 70-80% industrial ethanol.

4. The preparation method according to claim 2, characterized in that: The extraction in step (1) is reflux extraction, which is performed 2-3 times, each time for 3-4 hours.

5. A pharmaceutical composition comprising the vibsane-type diterpenoid compound or a salt thereof according to claim 1 and a pharmaceutically acceptable carrier or excipient.

6. Use of the vibsane-type diterpenoid compound or its salt according to claim 1 or the composition according to claim 5 in the preparation of antitumor drugs.

7. Use of the vibsane-type diterpenoid compound or its salt according to claim 1 or the composition according to claim 5 in the preparation of an anti-lung cancer drug.